ForSight Robotics
Robotic Platform for Ophthalmic Surgery
Company Overview
Snapshot
Founded in April 2020 by Daniel Glozman, Prof. Moshe, and Joseph Nathan, ForSight Robotics operates with 51–200 employees.
Business overview
ForSight Robotics is at the forefront of Health Tech & Life Sciences, developing a robotics-based surgical platform designed to enhance the precision of vision-saving ophthalmic procedures. Its core technology integrates robotic microsurgical instruments, advanced visualization technologies, and cognitive computing methods, including machine learning, to refine surgical techniques. The company primarily serves the healthcare industry, targeting providers and ultimately patients, within the medical devices and digital healthcare sectors.
Strategic signal
This funding underscores continued investor confidence in the company's innovative robotic platform for ophthalmic surgery and its potential to transform surgical precision and outcomes in the vision care market.
Company Intelligence Q&A
- When did ForSight Robotics raise its Series A funding?
- Investors included Precision Capital and Eclipse Ventures.
- Who are the founders of ForSight Robotics?
- ForSight Robotics was founded by Daniel Glozman, Prof. Moshe, and Joseph Nathan.
- What is the primary product offered by ForSight Robotics?
- ForSight Robotics offers ORYOM, a robotic platform designed for ophthalmic surgery.
- When did ForSight Robotics complete its Seed funding round?
- In March 2021, ForSight Robotics completed its Seed funding round, with Eclipse Ventures leading the investment and Mithril Capital Management also participating.